Yahoo Finance Markets betting on Biden-Harris win: advisor
Gerber said more companies may pursue stock splits after seeing Apple's and Tesla's shares pop on their split announcements.
Gerber said more companies may pursue stock splits after seeing Apple's and Tesla's shares pop on their split announcements.
Scott offered a glimpse of the outfits and accessories she packed for her pre-wedding getaway
Tesla stock slipped again on Tuesday, with shares now down nearly 9% since yesterday after the company announced a “more than 10%” staff reduction.
NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it has commenced an underwritten public offering of $500 million of shares of its common stock. In connection with the offering, Intra-Cellular Therapies intends to grant the underwriters a 30-day option to purchase up to
CHICAGO (Reuters) -United Airlines Holdings on Tuesday forecast stronger-than-expected earnings in the current quarter, after reporting a narrower-than-expected loss in the first quarter, on robust demand for travel. The Chicago-based carrier, which has been hit by Boeing's ongoing safety crisis, also slashed its total aircraft delivery estimates for this year to 66 from 88 estimated in February. It had to ground its Boeing 737 MAX 9 fleet following a January mid-air cabin panel blowout on an Alaska Airlines flight, resulting in a $200 million hit in the first quarter.
White House not rejecting House Speaker’s plan for separate defence funding bills for Israel and Ukraine
CONSHOHOCKEN, Pa., April 16, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), today announced that the company granted equity awards to 7 new employees, in each case with a grant date of April 15, 2024, as equity inducement awards under the terms of the company's 2023 Inducement Plan. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4). The equity a
AUSTIN, Texas, April 16, 2024 (GLOBE NEWSWIRE) -- Open Lending Corporation (NASDAQ: LPRO) (“Open Lending” or “the Company”), an industry trailblazer in automotive lending enablement and risk analytics solutions for financial institutions, today announced that the Company will host a conference call to discuss first quarter 2024 financial results on Tuesday, May 7, 2024 at 5:00pm ET. A press release with first quarter 2024 financial results will be issued after the market closes that same day. Th
BRISBANE, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devastating inflammatory-related diseases, today announced that it has granted inducement to two new non-executive employees under the terms of the 2022 Employment Inducement Award Plan. The equity awards were approved on April 12, 2024, in accordance with Nasdaq Listing Rule 5635(c)(4). In the ag
BOSTON, April 16, 2024 (GLOBE NEWSWIRE) -- Today, Flywire Corporation (Flywire) (Nasdaq: FLYW), a global payments enablement and software company, announced that its first quarter 2024 financial results will be released after market close on Tuesday, May 7, 2024. Flywire will host a conference call to discuss its first quarter 2024 financial results at 5:00pm ET the same day. Hosting the call will be Mike Massaro, CEO, Rob Orgel, President and COO, Cosmin Pitigoi, CFO, and Akil Hollis, Head of I
ASPIRE-FTD Sites in the EU and U.S. to Use ClearPoint® Navigation Together With SmartFlow® Cannula for Intrathalamic Gene Therapy AdministrationSOLANA BEACH, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today congratulates its partner AviadoBio on treating its first patient in the ASPIRE-FTD Phase 1/2 clinical trial evaluating its inves
DURHAM, N.C., April 16, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX) today announced that on April 10, 2024, the Compensation Committee of Chimerix’s Board of Directors granted inducement awards to four new employees of non-statutory stock options to purchase up to a total of 223,000 shares of Chimerix’s common stock. The Compensation Committee of Chimerix’s Board of Directors approved the awards as an inducement material to the new employees’ employment in accordance with Nasdaq Listing rule
NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced that William Ho, CEO and Co-founder, will present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference on Thursday, April 18th at 12:30pm ET. The formal presentation will feature a fireside style Q&A session with questions welcome from the live virtual audience. Attendees interested in
KING CITY, Ontario, April 16, 2024 (GLOBE NEWSWIRE) -- ClubLink Corporation ULC (subsidiary of TWC Enterprises Limited), Canada’s largest owner, operator and manager of Golf and Country Clubs, announced today that Vespra Hills Golf Club has joined the ClubLink family of managed Clubs. Established in 2003, nestled in the hills of Springwater Township, 10 minutes from downtown Barrie, Ontario and 45 minutes from the highway 407/400 interchange, the 27-hole Member Club will become a fully integrate
Singapore, April 16, 2024 (GLOBE NEWSWIRE) -- Kairous Acquisition Corp. Limited (NASDAQ: KACL, the “Company”), a special purpose acquisition company, announced today that Kairous Asia Limited, the Company’s initial public offering sponsor (“Sponsor”), has deposited into the Company’s trust account (the “Trust Account”) an aggregate of $50,000, in order to extend the period of time the Company has to complete a business combination for an additional one (1) month period, from April 16, 2024 to Ma
SOUTH JORDAN, Utah, April 16, 2024 (GLOBE NEWSWIRE) -- Cricut, Inc. (“Cricut”) (NASDAQ: CRCT), the creative technology company that has brought a connected platform for making to millions of users worldwide, today announced it will report its financial results for the first quarter ended March 31, 2024 after the U.S. markets close on Tuesday, May 7, 2024. Cricut management will host a conference call and webcast to discuss the results that afternoon at 3:00 p.m. Mountain Time (5:00 p.m. Eastern
EL SEGUNDO, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- A-Mark Precious Metals, Inc. (NASDAQ: AMRK) (A-Mark), a leading fully integrated precious metals platform, will hold a conference call on Tuesday, May 7, 2024 at 4:30 p.m. Eastern time to discuss results for the fiscal third quarter ended March 31, 2024. Financial results will be issued in a press release prior to the call. A-Mark management will host the presentation, followed by a question-and-answer period. A-Mark’s conference call can be
Net Asset Value Anticipated to be $6.90 to $7.40 Per ShareNEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: SSSS) today provided the following preliminary update on its investment portfolio for the first quarter ended March 31, 2024. “We remain incredibly enthusiastic about both our investment pipeline and our current portfolio as the IPO market strengthens and new opportunities at compelling valuations continue to com
Late breaking poster presentation includes Phase 1b clinical trial results demonstrating the safety and preliminary efficacy of KM-001, a topical TRPV3 inhibitor, for the treatment of palmoplantar keratoderma Oral presentation highlights favorable in vitro and in vivo safety and efficacy data of novel TRPV3 inhibitors KM-001(topical) and KM-023 (oral) in preclinical 3D skin and mouse models NESS ZIONA, Israel, April 16, 2024 (GLOBE NEWSWIRE) -- Kamari Pharma, a privately-held clinical stage biot
BETHESDA, Md. and MARINA DEL REY, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- iLearningEngines, Inc. (“iLearningEngines”, “iLE”, or “the Company”), a leader in AI-powered learning automation and information intelligence for corporate and educational use, is pleased to announce the completion of its business combination with Arrowroot Acquisition Corp. (formerly NASDAQ: ARRW, ARRWU, ARRWW) (“Arrowroot”). The combined company’s common stock and warrants are expected to commence trading on the Nasda
NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- New York Mortgage Trust, Inc. (Nasdaq: NYMT) (the “Company”) is scheduled to report financial results for the three months ended March 31, 2024 after the close of market on May 1, 2024. New York Mortgage Trust's executive management will host a conference call and audio webcast at 9:00 a.m., Eastern Time, on Thursday, May 2, 2024. To access the conference call, please pre-register using this link. Registrants will receive confirmation with dial-in det